Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Amexdrug Corporation

Healthcare US AXRX

NoneUSD
0.00(0%)

Last update at 2026-01-22T21:01:24.902117Z

Day Range

--
LowHigh

52 Week Range

0.00110.0021
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.34M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.38M
  • Revenue TTM9.17M
  • Revenue Per Share TTM0.05
  • Gross Profit TTM 1.01M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2012-12-31
Type yearly yearly yearly yearly yearly
Date 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2012-12-31
Income before tax 0.17M 0.11M 0.15M 0.12M 0.16M
Minority interest - - - - 0.00000M
Net income 0.11M 0.07M 0.10M 0.08M 0.08M
Selling general administrative 1.75M 1.45M 0.92M 0.92M 0.79M
Selling and marketing expenses - - - - -
Gross profit 1.97M 1.61M 1.09M 1.09M 1.01M
Reconciled depreciation - - - - -
Ebit 0.22M 0.14M 0.17M 0.14M 0.20M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income 0.21M 0.15M 0.17M 0.15M 0.20M
Other operating expenses 0.00742M 0.00790M 0.00922M 0.01M 0.00000M
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 0.06M 0.04M 0.05M 0.04M 0.08M
Total revenue 10.43M 9.30M 8.85M 8.63M 9.15M
Total operating expenses 0.00000M 0.00000M 0.00000M 0.00000M 8.95M
Cost of revenue 8.46M 7.70M 7.76M 7.55M 8.14M
Total other income expense net 0.00476M -0.00114M -0.00027M -0.00968M -0.03617M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 0.11M 0.07M 0.10M 0.08M 0.08M
Net income applicable to common shares 0.11M 0.07M 0.10M 0.08M 0.08M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2023-12-31 2021-12-31 2020-12-31 2019-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2021-12-31 2020-12-31 2019-12-31 2017-12-31
Total assets 2.46M 2.88M 3.70M 2.47M 2.31M
Intangible assets -0.01826M -0.01826M -0.01826M -0.01826M -
Earning assets - - - - -
Other current assets 0.09M 0.06M 0.06M 0.07M 0.33M
Total liab 0.71M 1.23M 2.18M 1.21M 1.51M
Total stockholder equity 1.75M 1.65M 1.52M 1.27M 0.81M
Deferred long term liab - - - - -
Other current liab 0.01M 0.00330M 0.00481M 0.00286M -
Common stock 0.17M 0.17M 0.17M 0.17M 0.17M
Capital stock - - - - -
Retained earnings 1.55M 1.40M 1.15M 1.29M 0.74M
Other liab - - - - -
Good will - - - - 0.02M
Other assets 0.00000M -0.00000M -0.00000M -0.00000M 0.03M
Cash 0.09M 0.74M 1.55M 0.45M 0.24M
Cash and equivalents - - - - -
Total current liabilities 0.22M 0.41M 1.25M 0.32M 1.51M
Current deferred revenue 0.00000M - 0.00000M - -
Net debt 0.40M 0.08M 0.42M 0.44M -
Short term debt 0.00105M - 1.04M - 0.69M
Short long term debt - - - - 0.69M
Short long term debt total 0.49M 0.81M 1.97M 0.89M -
Other stockholder equity 0.00000M -0.09522M 0.02M -0.36327M -
Property plant equipment - - - - 0.00847M
Total current assets 2.45M 2.87M 3.69M 2.48M 2.26M
Long term investments - - - - -
Net tangible assets - - - - 0.79M
Short term investments 1.22M 0.85M 0.45M 0.00964M 0.00960M
Net receivables 0.58M 0.43M 0.24M 0.61M 0.45M
Long term debt - - - - -
Inventory 0.48M 0.79M 1.39M 1.34M 1.23M
Accounts payable 0.20M 0.41M 0.21M 0.31M 0.82M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.04M 0.07M 0.19M -0.19386M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00000M 0.00000M 0.00000M 0.00000M -
Deferred long term asset charges - - - - -
Non current assets total 0.00504M 0.00504M 0.00504M -0.00249M -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2012-12-31
Type yearly yearly yearly yearly yearly
Date 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2012-12-31
Investments - - 0.00158M 0.00158M -0.00201M
Change to liabilities -0.11283M 0.35M 0.27M -0.22103M 0.28M
Total cashflows from investing activities - - 0.00078M -0.00140M -0.46060M
Net borrowings -0.00836M 0.10M 0.05M -0.04098M 0.46M
Total cash from financing activities -0.01064M 0.10M 0.04M -0.04328M 0.45M
Change to operating activities -0.17022M 0.06M -0.00914M 0.04M -0.03328M
Net income 0.11M 0.07M 0.10M 0.08M 0.08M
Change in cash 0.02M -0.01713M 0.06M 0.10M -0.17351M
Begin period cash flow - - - - -
End period cash flow - - - - -
Total cash from operating activities 0.03M -0.12120M 0.02M 0.14M -0.16080M
Issuance of capital stock - - - - -
Depreciation 0.00742M 0.00790M 0.00922M 0.01M 0.02M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory -0.20969M -0.39158M -0.16902M 0.22M -0.60276M
Change to account receivables 0.41M -0.21704M -0.18000M 0.00005M 0.11M
Sale purchase of stock -0.00227M -0.00093M -0.00110M -0.00230M 0.00000M
Other cashflows from financing activities - - - - -0.01100M
Change to netincome -0.00599M 0.00217M 0.00030M 0.01M -0.01559M
Capital expenditures 0.00000M 0.00000M 0.00080M 0.00140M 0.46M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AXRX
Amexdrug Corporation		 - -% - - - 0.04 51.38 3.76 89.93
ZTS
Zoetis Inc		 1.26 1.67% 77.16 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.23 0.75% 30.79 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 149.28 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 0.47 1.09% 43.41 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of prescription and over-the-counter drugs, non-drug products, and health and beauty products; and private manufacturing and labeling activities. Further, the company manufactures and sells facial and body creams, arthritic pain relief medications, and hair and nail care products to pharmacies, beauty salons, beauty supply stores, and other fine shops. Amexdrug Corporation markets its products under the Sponix name. The company distributes its products through its subsidiaries primarily to independent pharmacies and secondarily to small-sized pharmacy chains, alternative care facilities, and other wholesalers and retailers in the state of California. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000 to reflect the change in its business to the sale of pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California.

Amexdrug Corporation

7251 Condor Street, Commerce, CA, United States, 90040

Key Executives

Name Title Year Born
Mr. Jack Amin Chairman, CEO, Pres, CFO, Chief Accounting Officer, Sec. & Treasurer 1959
Mr. Jack Amin Chairman, CEO, President, CFO, Chief Accounting Officer, Secretary & Treasurer 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.